Development of Pediatric Acute Myeloid Leukemia Xenograft Models for the Testing of Targeted Therapeutic Agents

Completed NCT01576185

Study Description

These laboratory trial studies the development and treatment of a mouse model for acute myeloid leukemia (AML) using samples from younger patients with AML. Studying tissue samples from patients with cancer in the laboratory may help doctors learn more about cancer and how well patients will respond to treatment.

Study Details

Registry ID:
NCT01576185
Conditions:
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
Phase:
Target Enrollment:
10 participants
Start Date:
Age Range:
0–999 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →